Purpose:
Myocardial fibrosis is a key pathological driver of adverse clinical events, including sudden cardiac death and heart failure, in patients with hypertrophic cardiomyopathy (HCM). We previously identified WISPER, a novel cardiac fibroblast-specific long non-coding RNA (lncRNA), and demonstrated its associati...
Martin S. Maron, E. Rowin, Francesco Carelli et al.· Circulation· 0 citations
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease. Following advances in sudden cardiac death prevention, reducing limiting symptoms has become a key therapeutic goal, as nearly half of patients experience functional impairment. Although left ventricular (LV) outflow tract (LVOT) obst...
A. Schulz, E. Rowin, M. Ahluwalia et al.· European Heart Journal· 0 citations
Findings characterize the relapsing natural history of HCM-associated AF and underscore the need for further studies to optimize rhythm-control strategies in this population, regardless of rhythm-control strategy or AAD use.
Mauro Rogério de Barros Wanderley, Martin S. Maron, J. Silver et al.· Journal of Cardiovascular De...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.